Volume 19, Issue 7 (October 2021)                   Nursing and Midwifery Journal 2021, 19(7): 568-580 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pezeshki B, Bijani M, Dehghan A, Salehi Z. FACTORS OF POOR ADHERENCE TO INSULIN THERAPY IN PATIENTS WITH DIABETES MELLITUS AND THEIR FAMILIES. Nursing and Midwifery Journal 2021; 19 (7) :568-580
URL: http://unmf.umsu.ac.ir/article-1-4354-en.html
1- Assistant Professor, Fasa University of Medical Sciences, Fasa, Iran (Corresponding Author) , babakpezeshki@yahoo.com
2- Assistant Professor, Fasa University of Medical Sciences, Fasa, Iran
3- Medical Student, Fasa University of Medical Sciences, Fasa, Iran
Abstract:   (819 Views)
Background & Aims: Diabetes Mellitus (DM) is the most common chronic disease in the world that is the major risk factor of fatal diseases such as myocardial infarction and stroke also the complication of DM is a common cause of disability. The most important treatment to control DM is insulin therapy however, due to several factors, patients do not tolerate this method. We aimed to identify the factors affecting poor adherence to insulin therapy in the patients and families. Materials & Methods: This study was performed on 216 patients (108 patients with diabetes and 108 families). Demographic information and insulin rejection questionnaire were completed by patients and patients' families. Data were compared based on the Mann-Whitney and independent t-tests. Results: Findings of our study showed that among the group of diabetic patients, mean and standard deviation of the score of factors such as fear of needle, injection site pain, additional cost, family injury with needle, other people's experiences, psychological trauma, injection difficulty, fear of side effects ratio, and other factors were significantly higher and they were the most important reasons for not taking insulin in this group. Among the diabetic family group, the mean and standard deviation of the score of factors such as family dependence, fear of needles, injection site pain, additional cost, other people's experiences, trauma, injection difficulty, and fear of complications were significantly higher than other factors. Conclusion: Based on the results, most of the barriers to the non-use of insulin are due to unnecessary fears in patients that training and eliminating the barriers with training classes can increase patients' compliance with insulin and increase their adherence to the treatment regimen.
Full-Text [PDF 563 kb]   (279 Downloads)    
Type of Study: Research | Subject: متفرقه

1. Longo DL FA, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. New York: Mcgraw-hill; 2018. [URL]
2. Tanjani PT, Moradinazar M, Mottlagh ME, Najafi F. The prevalence of diabetes mellitus (DM) type II among Iranian elderly population and its association with other age-related diseases, 2012. J Arch Gerontol Geriatr 2015;60(3):373-9. [DOI:10.1016/j.archger.2014.11.012] [PMID]
3. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes Res Clin Pract 2014;103(2):319-27. [DOI:10.1016/j.diabres.2013.12.034] [PMID]
4. Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M. Prevalence of diabetes type 2 in older adults: Findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes Metab Syndr 2017;11 Suppl 1:S347-S50. [DOI:10.1016/j.dsx.2017.03.014] [PMID]
5. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis. PLoS One2015;10(7):e0132505. [DOI:10.1371/journal.pone.0132505] [PMID] [PMCID]
6. Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabetes Obes Metab 2012;14(12):1081-7. [DOI:10.1111/j.1463-1326.2012.01636.x] [PMID]
7. Jahani S, Majdzade R, Ghorbani M, Khosravi S, Bajuri A, Amini S, et al. Investigating the effective factors in diabetic patients' reluctance to insulin therapy in patients referred to diabetes centers in 2010-2011: A qualitative study. IJDLD 2011;10(5):520-7. [Google Scholar]
8. Farsaei S, Radfar M, Heydari Z, Abbasi F, Qorbani M. Insulin adherence in patients with diabetes: risk factors for injection omission. Prim Care Diabetes 2014;8(4):338-45. [DOI:10.1016/j.pcd.2014.03.001] [PMID]
9. Pezeshki B, Karimi A, Ansari A, Elmi M, Nikmanesh A, Moalemi S, et al. Fasa Registry on Diabetes mellitus (FaRD): Feasibility Study and Pilot Phase Results. Galen Medical Journal 2021;10(0):2137. [DOI:10.31661/gmj.v10i0.2137]
10. Habibi R, Soltani M, Habibi G. Evaluation of factors affecting insulin rejection by diabetic patients. IJDM 2012;11(4):366-76. [Google Scholar]
11. Zare'Shahabadi A, Ebrahimi Sadrabadi F. Impact of cognitive factors on treatment of Type 2 Diabetes in Yazd. Clinical Psychology Studies 2013;4(13):1-22. [Google Scholar]
12. Jafarian N, Heydari A. The Study of the Role of Health Beliefs for Insulin Injection Compliance in Diabetes Patients Referred to Hamadan Diabetic Research Center in 1998. Avicenna J Clin Med 2001;7(4):0-. [Google Scholar]
13. Guimaraes C, Marra CA, Colley L, Gill S, Simpson SH, Meneilly GS, et al. A valuation of patients' willingness-to-pay for insulin delivery in diabetes. Int J Technol Assess Health Care 2009;25(3):359. [DOI:10.1017/S0266462309990055] [PMID]
14. Brod M, Kongs JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18(1):23-32. [DOI:10.1007/s11136-008-9419-1] [PMID]
15. Riaz M, Basit A, Fawwad A, Ahmedani MY, Rizvi ZA. Factors associated with non-adherence to insulin in patients with type 1 diabetes. Pak J Med Sci Q 2014;30(2):233. [DOI:10.12669/pjms.302.4747]
16. Chen K-W, Tseng H, Huang Y, Chuang Y. The barriers to initiating insulin therapy among people with Type 2 diabetes in Taiwan-a qualitative study. J Diabetes Metab Disord 2012;3:194. [URL]
17. Saeidinejat S, Chahipour M, Esmaily HV, Ghonche H, Fathalizadeh S, Omidbakhsh R. Role of family support in self care of Type II diabetic patients. Iran J Endocrinol Metab 2014;16(2):95-102. [URL]
18. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. j Clin Ther 2005;27(7):1064-73. [DOI:10.1016/j.clinthera.2005.07.009] [PMID]
19. Demoz GT, Wahdey S, Bahrey D, Kahsay H, Woldu G, Niriayo YL, et al. Predictors of poor adherence to antidiabetic therapy in patients with type 2 diabetes: a cross-sectional study insight from Ethiopia. J Diabetes Metab Disord 2020;12(1):1-8. [DOI:10.1186/s13098-020-00567-7] [PMID] [PMCID]
20. Weerakoon LN, Amarasekara TD, Jayasekara R. Factors Affecting Adherence to Insulin Therapy among Patients with Type 2 Diabetes Mellitus in a Selected Teaching Hospital, Sri Lanka. J Sci Tech Res 2020;30(4):23608-14. [DOI:10.26717/BJSTR.2020.30.004990]
21. Krishnakumar S, Govindarajulu Y, Vishwanath U, Nagasubramanian VR, Palani T. Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India. J Diabetes Metab Syndr: Clin Res Rev 2020;14(5):1379-83. [DOI:10.1016/j.dsx.2020.07.026] [PMID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Nursing And Midwifery Journal

Designed & Developed by : Yektaweb